Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 747.06

-0.9%

2:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (62)	3/26/1997 2:33:00 AM
From: James Silverman	of 3559

Thanks for the reply. REGN is tough to keep track of. So bottom line is GNE may be ahead of AMGN/REGN for ALS? If this is the case the recent setback looms larger. Which stock do you prefer, CTII or REGN? I loved the deal CTII struck with the conus snail innovator. As an aside and pure speculation I get the feeling he got shafted by NXCO and this is why he spurned them. If they can effectively assay this I would hope they could identify several leads. I've been looking (briefly) at CTII and you have nailed a big question. Its easy to see where your specialties are-with NXCO, REGN, CTII SIBI etc. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next